Ultralife Corp. (NASDAQ: ULBI) reported Q1 EPS of $0.93, versus ($0.07) reported last year. Revenue for the quarter came in at $19.2 million, versus $15.3 million reported last year.

Ultralife's Board of Directors has authorized an extension of the Company's share repurchase program for an additional twelve month period beginning May 1, 2015 and ending April 30, 2016, subject, for the entire period as extended, to the 1.8 million share aggregate limit established in the initial authorization. Since the inception of the share repurchase program on May 1, 2014, the Company has repurchased 388,122 shares.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.